Drug Database
SI

simvastatin + triflusal (IRIST stent)

✓ Approved

Palau Pharma · HMGCR · 小分子

什么是 simvastatin + triflusal?

simvastatin + triflusal 是一种小分子,由Palau Pharma研发。该药已获批,用于治疗相关适应症,给药途径:Surgical Implantation。

药物档案

商品名IRIST stent
公司Palau Pharma
药物类别小分子
分子靶点HMGCR, PDE4A, PDE4B, PDE4C, PDE4D, PTGS1, PTGS2
给药途径Surgical Implantation
状态Approved

作用机制

分子靶点

simvastatin + triflusal 作用于 7 个分子靶点:

HMGCR3-hydroxy-3-methylglutaryl-CoA reductase (LDLCQ3, MYPLG)
PDE4Aphosphodiesterase 4A (PDE4, DPDE2)
PDE4Bphosphodiesterase 4B (PDEIVB, DPDE4)
PDE4Cphosphodiesterase 4C (DPDE1, PDE21)
PDE4Dphosphodiesterase 4D (PDE43, STRK1)
PTGS1prostaglandin-endoperoxide synthase 1 (PCOX1, COX3)
PTGS2prostaglandin-endoperoxide synthase 2 (PHS-2, GRIPGHS)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

simvastatin + triflusal 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Injury, poisoning and procedural complicationsRestenosis✓ Approved

相关研究文献

PubMedEJVES vascular forum2026-11-17

Venous Hypertension Associated with an Abnormal Configuration of a Protruding Cephalic Arch Stent in Arteriovenous Haemodialysis Access: A Case Report.

Suzuki Haruo H, Hirai Yasutaka Y, Fujiwara Masato M

Cephalic arch stenosis is a common cause of access dysfunction in brachiocephalic arteriovenous fistulae, and recurrent lesions are often treated with stent placement. Although stent protrusion into the axillary vein is frequently tolerated, an abnormal stent-vein configuration combined with in stent re-stenosis may impair physiological venous drainage. This case report presents severe venous hypertension resulting from in stent re-stenosis within the protruding segment impairing physiological axillary venous outflow and an abnormal stent-vein configuration caused by stent tip contact with the opposite axillary vein wall, redistributing access flow. A 75 year old man receiving long term haemodialysis developed upper extremity oedema and prolonged post-dialysis bleeding from his brachiocephalic arteriovenous fistula. Computed tomography showed a cephalic arch stent protruding across the cephalic axillary junction, its tip contacting the axillary vein wall opposite the junction. Access fistulography demonstrated severe in stent re-stenosis with neointimal hyperplasia reducing the available sidewall openings. Through the remaining patent openings, part of the access flow continued centrally and part was redirected into the axillary venous segment peripheral to the cephalic axillary junction, with retrograde opacification and subsequent collateral drainage. The protruding stent segment was excised, and the axillary vein reconstructed with a patch. After surgery, oedema improved, collateral venous flow decreased, and the access remained functional at one year despite residual re-stenosis. This case demonstrates that cephalic arch stent protrusion may become clinically significant when in stent re-stenosis within the protruding segment impairs axillary venous outflow and the stent-vein configuration causes access flow redistribution. In this patient, neointimal hyperplasia reduced the sidewall openings, impairing physiological axillary venous outflow, while residual openings allowed redistribution of access flow into the peripheral axillary venous segment. Recognition of this abnormal stent-vein configuration and flow pattern is important because open surgical reconstruction may be required to restore venous drainage while preserving haemodialysis access function.

PMID 43041211
阅读全文 →
PubMedNeurological research2026-11-17

Safety and efficacy of self-expanding stents for symptomatic severe intracranial posterior circulation stenosis: a two-center prospective cohort study.

He Rongxin R, Zhao Zhenghua Z, Wang Shuangjie S, Nong Jing J et al.

Intracranial atherosclerotic stenosis (ICAS) of the posterior circulation is a common neurological condition, and the efficacy of endovascular therapy remains controversial. In this two-center prospective cohort study, 120 consecutive patients with severe posterior circulation ICAS were enrolled and divided into a stent group or a medication group based on clinical decision-making. To minimize selection bias, propensity score matching (PSM) was also applied to balance baseline covariates between the two groups. Clinical outcomes and angiographic follow-up were assessed at 6 months. At the 6-month follow-up, the stent group exhibited significantly lower vascular stenosis rates (35.58 ± 12.25% vs. 78.00 ± 7.82%, p < 0.001) and NIHSS scores (0.80 ± 0.73 vs. 1.38 ± 1.19, p = 0.002) compared to the medication group. A significantly higher proportion of patients in the stent group achieved a Barthel Index ≥60 (59 vs. 52, p = 0.038). Additionally, the relief of dizziness was significantly superior in the stent group (p = 0.032). Asymptomatic in-stent restenosis occurred in 3 cases in the stent group, with no recurrent cerebral infarctions observed, whereas 2 recurrent strokes occurred in the medication group. Self-expanding stenting is a safe and effective strategy for symptomatic severe posterior circulation ICAS, improving vascular patency while showing potential benefits for neurological recovery.

PMID 43042968
阅读全文 →
PubMedCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions2026-11-17

The CLEAR Classification for Coronary Bifurcation In-Stent Restenosis: An Exploratory Cohort Study.

Khelimskii Dmitrii D, Manukian Serezha S, Bessonov Ivan I, Sapozhnikov Stanislav S et al.

In-stent restenosis (ISR) following percutaneous coronary intervention for bifurcation lesions remains a challenging clinical entity. Existing classifications do not fully characterize bifurcation ISR by integrating relevant anatomical and procedural characteristics. To propose a novel classification for bifurcation ISR and to explore its associations with observed management patterns and long-term outcomes. A novel classification for bifurcation ISR, incorporating core involvement, stent layer number, and morphological pattern, was applied to angiographic data from 98 patients (from a cohort of 600 patients with angiographic follow-up after bifurcation stenting). Interobserver reproducibility of the classification was assessed using paired ratings obtained from two independent observers. Subsequently, treatment approaches and clinical outcomes were evaluated over a median follow-up of 3.5 years. The classification identified several angiographic phenotypes that appeared to be associated with different observed treatment patterns and numerically different clinical outcomes. Interobserver agreement was excellent, with kappa values from 0.843 to 0.882. Isolated side branch (21 patients) and focal main branch (31 patients) ISR, particularly without core involvement (22 patients), were associated with favorable outcomes and were predominantly managed with repeat stenting, plain balloon angioplasty, or optimal medical therapy. In contrast, patients with ISR involving both branches (n = 23) or diffuse main-branch ISR (n = 23) were managed using a wider range of approaches and had higher recurrence rates. Restenosis within areas of multiple stent layers (13 patients) also correlated with complex management. The CLEAR classification provides a structured angiographic framework for describing bifurcation lesion ISR. In this exploratory cohort, CLEAR phenotypes were associated with different observed treatment patterns and clinical outcomes; however, these findings should be considered hypothesis-generating and require prospective validation before the classification can be used to guide treatment strategies.

PMID 43042645
阅读全文 →
PubMedPakistan journal of medical sciences2026-11-17

Comparison of short-term myocardial perfusion and clinical outcomes between balloon stent kissing technique and junctional wire technique strategies in true bifurcation lesions of the left anterior descending artery and diagonal branch.

Ren Kai K, Wang Hongyu H, Li Ximing X

To compare procedural, clinical, and myocardial perfusion outcomes associated with the Balloon Stent Kissing Technique (BSKT) and Junctional Wire Technique (JWT) in patients with true bifurcation lesions of the left anterior descending artery (LAD) and diagonal branch. A retrospective analysis included data from 235 patients who underwent treatment of true bifurcation lesions of the coronary LAD and diagonal branch at Tianjin University Chest Hospital, China; between February 2023 to October 2024. All patients were followed up for one year. Based on the technique, patients were divided into the BSKT (n=111) and the JWT (n=124) groups. Efficacy, safety profiles, and myocardial perfusion parameters were compared between the two groups. In the unadjusted analysis, BSKT was associated with a higher immediate stent implantation success rate and a lower incidence of provisional stenting (PS-T) due to branch compromise. After adjustment for potential confounders, the association with immediate stent implantation success was attenuated and became borderline significant. No statistically significant between-group differences were detected in the one-year clinical outcomes; however, the small number of events limited definitive comparison between the two strategies. On postoperative Day 1, BNP and cTnT levels remained lower in the BSKT group after correction for repeated longitudinal comparisons, whereas the difference in CK-MB was attenuated after multiple-comparison correction. At six months, the BSKT group showed more favorable selected SPECT-derived parameters, including a lower stress myocardial perfusion score, fewer resting and stress myocardial perfusion-defect segments, and a narrower range of abnormal myocardial perfusion, whereas the resting myocardial perfusion score did not differ significantly between groups. Compared with JWT, BSKT was associated with more favorable findings in side-branch protection and selected short-term functional outcomes in patients with LAD-diagonal branch true bifurcation lesions, whereas comparative long-term clinical outcomes remain uncertain.

PMID 43042074
阅读全文 →
PubMedNature communications2026-11-17

Low-Dose Glucocorticoids Adjunctive to Flow Diverter Therapy for Unruptured Intracranial Aneurysms Improve Cerebrovascular Outcomes.

Wen Zhuohua Z, Chen Xiheng X, Tong Xin X, Huang Chi C et al.

Flow diverter (FD) implantation is standard for unruptured intracranial aneurysms (UIAs), but cerebrovascular complications persist. This nested study within a prospective multicenter cohort evaluates whether short-term, low-dose glucocorticoid use is associated with cerebrovascular outcomes after FD implantation. Propensity-score matching with exact matching on UIA location yielded 1327 patients (360 glucocorticoid-treated; 967 controls). Intravenous glucocorticoids, initiated within 2 hours of the FD procedure and administered for ≥2 days, were associated with fewer in-hospital cerebrovascular events (6.9% vs. 13.1%; adjusted odds ratio [aOR], 0.53) and major cerebrovascular events (4.7% vs. 12.4%; aOR, 0.37). Over a median 2-year follow-up, glucocorticoid use was also associated with fewer new-onset major cerebrovascular events (3.6% vs. 8.7%; adjusted hazard ratio, 0.41) and less in-stent stenosis (7.9% vs. 13.2%; aOR, 0.55). Findings remained robust in unmatched patients on sensitivity analyses. We demonstrate that perioperative glucocorticoid regimens may reduce cerebrovascular events and in-stent stenosis in FD-treated patients, warranting randomized trials.

PMID 43039903
阅读全文 →
PubMedCirculation. Cardiovascular interventions2026-11-17

Temporal and Vessel-Specific Relationship Between Post-PCI Fractional Flow Reserve and Long-Term Clinical Outcomes.

Kanaji Yoshihisa Y, Hwang Doyeon D, Usui Eisuke E, Ueno Hiroki H et al.

Post-percutaneous coronary intervention (PCI) fractional flow reserve (FFR) reflects residual physiological impairment after stent implantation and is a proven predictor of procedural success and prognosis. However, the temporal dynamics of its prognostic utility and its potential variation according to the target vessel remain incompletely understood. This study aimed to explore vessel-specific post-PCI FFR thresholds and evaluate their prognostic consistency over 5 years. We analyzed 2128 patients undergoing successful drug-eluting stent implantation from the international Post-PCI FFR Extended registry. Patients were stratified according to the target vessel: left anterior descending artery (LAD) versus non-LAD. The primary end point was 5-year target vessel failure, defined as a composite of cardiac death, target vessel myocardial infarction, or target vessel revascularization. Restricted cubic spline models were used to explore the continuous association between post-PCI FFR and target vessel failure and to identify vessel-specific risk thresholds. Temporal prognostic performance was assessed via 3-year landmark analysis and time-dependent receiver-operating characteristic curves. During 5-year follow-up, target vessel failure occurred in 176 patients (11.7%) with LAD lesions and 74 patients (11.7%) with non-LAD lesions. Lower post-PCI FFR was independently associated with a higher risk of target vessel failure in both LAD and non-LAD vessels. Spline analyses characterized vessel-stratified risk patterns, and exploratory comparisons used post-PCI FFR cut points of 0.83 for LAD and 0.94 for non-LAD vessels. Landmark analysis indicated that the excess hazard associated with suboptimal FFR was predominantly concentrated within the first 3 years postprocedure. Nevertheless, time-dependent receiver-operating characteristic analysis demonstrated modest but stable discriminatory power of post-PCI FFR throughout the 5-year follow-up. Post-PCI FFR provides sustained 5-year prognostic insight, though the exploratory vessel-stratified cut points require external validation. Although the associated risk is highest in the early to mid-term period, predictive discrimination persists long-term. These findings advocate for vessel-specific interpretation of post-PCI physiology to refine risk stratification and patient management.

PMID 43042474
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多simvastatin + triflusal